Board Member
Neurocrine Biosciences Inc (NBIX)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
Recorded current and former roles; source labels appear when available.
2008-01-01–present
Recorded roles and earnings-call appearances connecting this person to public companies.
CEO, Board Member
2008-01-01–present
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2024 | Neurocrine Biosciences Inc (NBIX) | CEO | $779,357 | $16,018,637 |
| 2023 | Neurocrine Biosciences Inc (NBIX) | CEO | $946,000 | $15,750,812 |
| 2022 | Neurocrine Biosciences Inc (NBIX) | CEO | $860,000 | $11,902,527 |
| 2021 | Neurocrine Biosciences Inc (NBIX) | CEO | $825,000 | $14,081,412 |
| 2020 | Neurocrine Biosciences Inc (NBIX) | CEO | $775,000 | $13,880,632 |
| 2019 | Neurocrine Biosciences Inc (NBIX) | CEO | $725,000 | $9,450,826 |
| 2018 | Neurocrine Biosciences Inc (NBIX) | CEO | $675,000 | $8,632,979 |
| 2017 | Neurocrine Biosciences Inc (NBIX) | CEO | $640,000 | $7,556,374 |
Earnings-call appearances and filed executive appointments or departures, newest first.
